Skip to main content

DIEBOLD NIXDORF, Inc

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

DBD$57.34-4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Liquidity and Capital Resources

Liquidity and Capital Resources. On December 18, 2024, the Company issued $950.0 in aggregate principal amount of 7.75% Senior Secured Notes due 2030 (the 2030 Senior Secured Notes) to qualified institutional buyers in a private placement exempt from the registration requirements of the Securities Act of 1933. On December 18, 2024, the Company also entered into a new revolving credit facility agreement (the Revolving Credit Facility) with certain financial institutions for $310.0 maturing on December 18, 2029. Refer to Note 9 of the condensed consolidated financial statements for additional information.

Credit Ratings and Conditions. The cost and availability of debt financing is influenced by our credit ratings. Moody's Investors Service (Moody's) and Standard and Poor's Global Ratings (S&P) currently issue ratings on our short- and long-term debt. On December 10, 2024, Moody's revised our rating from "B3" to "B2" with a stable outlook. On September 18, 2025, S&P raised our issuer rating to "B+" from "B" and assigned a stable outlook. Our ratings may be subject to a revision or withdrawal at any time by the assigning rating organization, and each rating should be evaluated independently of any other rating.

Moody'sS&P
OutlookStableStable
Long-termB2B+

We believe that cash from operations plus available borrowing capacity under our Revolving Credit Facility, our current cash balance, and short-term investments are adequate to support operating requirements, capital expenditures and any share repurchases for at least the next 12 months and the foreseeable future thereafter. As of September 30, 2025 and December 31, 2024, we had no borrowings outstanding under the $310.0 Revolving Credit Facility,$24.3 and$21.9, respectively, of outstanding letters of credit and available borrowing capacity of $285.7 and 288.1, respectively.

September 30, 2025December 31, 2024
Cash and cash equivalents$246.1$296.2
Short-term investments17.416.9
Revolving credit facility310.0310.0
Total$573.5$623.1

The following table summarizes the results of the Company's Statement of Cash Flows:

Nine months ended September 30,
Summary of cash flows:20252024
Net cash provided (used) by operating activities$83.2$(47.0)
Net cash used by investing activities(59.0)(28.2)
Net cash used by financing activities(88.2)(174.5)
Effect of exchange rate changes on cash, cash equivalents and restricted cash15.3(8.2)
Change in cash, cash equivalents and restricted cash$(48.7)$(257.9)

Operating Activities. Cash flows from operating activities can fluctuate significantly from period to period as working capital needs and the timing of payments impact reported cash flows. Cash flows from operating activities during the nine months ended September 30, 2025 were driven by cash provided by trade receivables and cash uses for inventories, accounts payable, and deferred revenue. The key drivers of these cash flows are increased collections and supplier payments. Cash flows from operating activities during the nine months ended September 30, 2024 were driven by cash provided by trade receivables and cash uses from inventories, accounts payable, and deferred revenue. The key drivers of these cash flows are timing of sales, collections, and vendor payments.

Investing Activities. Cash flows used by investing activities during the nine months ended September 30, 2025 and 2024 were driven by short term investments, $18.4 of investments in multi-vendor capabilities and premium service offering in North America and other strategic business investments to enhance our solutions portfolio, capital expenditures, and internally developed software, partially offset by the sale of short term investments.

Financing Activities. Cash flows used by financing activities during the nine months ended September 30, 2025 were primarily driven by the Company's repurchase of common shares. Cash flows from financing activities during the nine months ended September 30, 2024 primarily relate to the repayment of the Exit Facility (as defined below).

Share Repurchase. On February 12, 2025, we announced that our Board had approved a $100.0 share repurchase program for the purchase of our common stock. During the first quarter of 2025, the Company purchased 184,961 shares for $8.0 in aggregate. In the second quarter of 2025, the Company purchased 636,781 shares for $29.9 in the aggregate. In the third quarter of 2025, the Company purchased 667,401 shares for $39.5 in the aggregate. As of September 30, 2025, there was $22.6 remaining under the share repurchase program. Subsequently, we repurchased the remaining $22.6 in the fourth quarter of 2025. On November 5, 2025, we announced that our Board had approved a new $200.0 share repurchase program for the purchase of our common stock. Under the share repurchase program, shares may be repurchased in the open market, or otherwise, including under accelerated share repurchase programs, or under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (Exchange Act). The specific timing, price, and size of purchases will depend on prevailing stock prices, general market and economic conditions, and other considerations. The program may be extended, suspended, or discontinued at any time without prior notice and does not obligate us to acquire any particular amount of common stock. Refer to Unregistered Sales of Equity Securities and Use of Proceeds in Part II of this Quarterly Report on Form 10-Q for more information.

Contractual and Other Material Cash Obligations. All contractual and other cash obligations with initial and remaining terms in excess of one year and contingent liabilities remained generally unchanged at September 30, 2025 compared to December 31, 2024. Please refer to the Contractual and Other Obligations in the MD&A of our Annual Report on Form 10-K for the year ended December 31, 2024 for further information.

Off-Balance Sheet Arrangements. Please refer to Note 12 of the condensed consolidated financial statements for additional information.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.